Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. Country Market: CAGR Calculation
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Intracranial Stenosis Stents Market Snapshot
2.2. Intracranial Stenosis Stents Market Segment Snapshot
2.3. Intracranial Stenosis Stents Market Competitive Landscape Snapshot
Chapter 3. Intracranial Stenosis Stents Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of intracranial disease
3.2.1.2. Increasing preference for minimally invasive procedures
3.2.2. Market Restraint Analysis
3.2.2.1. Cerebrovascular complications related to intracranial stenting
3.2.2.2. Lack of skilled professionals
3.3. Intracranial Intracranial Stents Market Analysis Tools
3.3.1. Intracranial Intracranial Intracranial Market – PESTLE Analysis
3.3.2. Industry Analysis – PORTER’S FIVE Forces
3.4. COVID-19 Impact on Intracranial Stenosis Stents Market
Chapter 4. Intracranial Stenosis Stents Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Intracranial Stenosis Stents Market: Product Movement Analysis, USD Million, 2022 & 2030
4.2.1. Self-expanding Stents
4.2.1.1. Self-expanding Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.2. Embolization Coil Support Intracranial Stents
4.2.2.1. Embolization Coil Support Intracranial Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.3. Venous Sinus Stents
4.2.3.1. Venous Sinus Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.4. Balloon-expanding & Other stents
4.2.4.1. Balloon-expanding & Other stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5. Intracranial Stenosis Stents Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Intracranial Stenosis Stents Market: End Use Movement Analysis, USD Million, 2022 & 2030
5.2.1. Hospitals
5.2.1.1. Hospitals Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.2.2. Ambulatory Surgical Centers
5.2.2.1. Ambulatory Surgical Centers Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.2.3. Others
5.2.3.1. Others Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6. Intracranial Stenosis Stents Market: Regional Estimates & Trend Analysis
6.1. Intracranial Stenosis Stents Market: Regional Movement Analysis, 2022 & 2030
6.2. North America
6.2.1. North America Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Prevalence Insights
6.2.2.3. Regulatory Framework
6.2.2.4. Reimbursement Scenario
6.2.2.5. U.S. Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Prevalence Insights
6.2.3.3. Regulatory Framework
6.2.3.4. Reimbursement Scenario
6.2.3.5. Canada Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3. Europe
6.3.1. Europe Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Prevalence Insights
6.3.2.3. Regulatory Framework
6.3.2.4. Reimbursement Scenario
6.3.2.5. UK Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Prevalence Insights
6.3.3.3. Regulatory Framework
6.3.3.4. Reimbursement Scenario
6.3.3.5. Germany Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Prevalence Insights
6.3.4.3. Regulatory Framework
6.3.4.4. Reimbursement Scenario
6.3.4.5. France Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Prevalence Insights
6.3.5.3. Regulatory Framework
6.3.5.4. Reimbursement Scenario
6.3.5.5. Italy Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Prevalence Insights
6.3.6.3. Regulatory Framework
6.3.6.4. Reimbursement Scenario
6.3.6.5. Spain Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Prevalence Insights
6.3.7.3. Regulatory Framework
6.3.7.4. Reimbursement Scenario
6.3.7.5. Denmark Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Prevalence Insights
6.3.8.3. Regulatory Framework
6.3.8.4. Reimbursement Scenario
6.3.8.5. Sweden Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Prevalence Insights
6.3.9.3. Regulatory Framework
6.3.9.4. Reimbursement Scenario
6.3.9.5. Norway Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Prevalence Insights
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Scenario
6.4.2.5. Japan Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Prevalence Insights
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Scenario
6.4.3.5. China Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Prevalence Insights
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Scenario
6.4.4.5. India Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. Key Country Dynamics
6.4.5.2. Prevalence Insights
6.4.5.3. Regulatory Framework
6.4.5.4. Reimbursement Scenario
6.4.5.5. South Korea Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Prevalence Insights
6.4.6.3. Regulatory Framework
6.4.6.4. Reimbursement Scenario
6.4.6.5. Australia Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Prevalence Insights
6.4.7.3. Regulatory Framework
6.4.7.4. Reimbursement Scenario
6.4.7.5. Thailand Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Prevalence Insights
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Scenario
6.5.2.5. Brazil Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Prevalence Insights
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Scenario
6.5.3.5. Mexico Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Prevalence Insights
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Scenario
6.5.4.5. Argentina Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.6. Middle East & Africa
6.6.1. Middle East & Africa Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Prevalence Insights
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Scenario
6.6.2.5. South Africa Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Prevalence Insights
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Scenario
6.6.3.5. Saudi Arabia Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Prevalence Insights
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Scenario
6.6.4.5. UAE Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Prevalence Insights
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Scenario
6.6.5.5. Kuwait Intracranial Stenosis Stents Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Key Company Market Position Analysis
7.4. Key Company Market Share Analysis
7.5. Company Profiles/Listing
7.5.1. phenox GmbH
7.5.1.1. Overview
7.5.1.2. Financial Performance (Net Revenue)
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Medtronic
7.5.2.1. Overview
7.5.2.2. Financial Performance (Net Revenue)
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Acandis GmbH
7.5.3.1. Overview
7.5.3.2. Financial Performance (Net Revenue)
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. MicroPort Scientific Corporation
7.5.4.1. Overview
7.5.4.2. Financial Performance (Net Revenue)
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. MicroVention, Inc.
7.5.5.1. Overview
7.5.5.2. Financial Performance (Net Revenue)
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. CERENOVUS (Johnson & Johnson)
7.5.6.1. Overview
7.5.6.2. Financial Performance (Net Revenue)
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Sino Medical Sciences Technology, Inc.
7.5.7.1. Overview
7.5.7.2. Financial Performance (Net Revenue)
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Stryker
7.5.8.1. Overview
7.5.8.2. Financial Performance (Net Revenue)
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Balt
7.5.9.1. Overview
7.5.9.2. Financial Performance (Net Revenue)
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
Chapter 8. Analyst Perspective
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/